China Regenerative Medicine International Limited

SEHK:8158 Stok Raporu

Piyasa değeri: HK$95.8m

China Regenerative Medicine International Yönetim

Yönetim kriter kontrolleri 3/4

China Regenerative Medicine International CEO'su Chuang Wang, Jul2020 tarihinde atandı, in görev süresi 4.33 yıldır. in toplam yıllık tazminatı HK$ 1.46M olup, şirket hissesi ve opsiyonları dahil olmak üzere 85.3% maaş ve 14.7% ikramiyelerden oluşmaktadır. şirketin hisselerinin 24.28% ine doğrudan sahiptir ve bu hisseler HK$ 23.27M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4.3 yıl ve 3.9 yıldır.

Anahtar bilgiler

Chuang Wang

İcra Kurulu Başkanı

HK$1.5m

Toplam tazminat

CEO maaş yüzdesi85.3%
CEO görev süresi4.3yrs
CEO sahipliği24.3%
Yönetim ortalama görev süresi4.3yrs
Yönetim Kurulu ortalama görev süresi3.9yrs

Son yönetim güncellemeleri

Recent updates

Little Excitement Around China Regenerative Medicine International Limited's (HKG:8158) Revenues As Shares Take 32% Pounding

Mar 05
Little Excitement Around China Regenerative Medicine International Limited's (HKG:8158) Revenues As Shares Take 32% Pounding

China Regenerative Medicine International Limited's (HKG:8158) Price Is Right But Growth Is Lacking After Shares Rocket 57%

Jan 04
China Regenerative Medicine International Limited's (HKG:8158) Price Is Right But Growth Is Lacking After Shares Rocket 57%

These 4 Measures Indicate That China Regenerative Medicine International (HKG:8158) Is Using Debt Extensively

Sep 21
These 4 Measures Indicate That China Regenerative Medicine International (HKG:8158) Is Using Debt Extensively

China Regenerative Medicine International Limited (HKG:8158) May Have Run Too Fast Too Soon With Recent 31% Price Plummet

Jun 11
China Regenerative Medicine International Limited (HKG:8158) May Have Run Too Fast Too Soon With Recent 31% Price Plummet

Is China Regenerative Medicine International (HKG:8158) A Risky Investment?

May 22
Is China Regenerative Medicine International (HKG:8158) A Risky Investment?

Is China Regenerative Medicine International (HKG:8158) A Risky Investment?

Apr 13
Is China Regenerative Medicine International (HKG:8158) A Risky Investment?

Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?

Sep 22
Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?

Introducing China Regenerative Medicine International (HKG:8158), The Stock That Zoomed 142% In The Last Year

Mar 16
Introducing China Regenerative Medicine International (HKG:8158), The Stock That Zoomed 142% In The Last Year

What Is The Ownership Structure Like For China Regenerative Medicine International Limited (HKG:8158)?

Feb 08
What Is The Ownership Structure Like For China Regenerative Medicine International Limited (HKG:8158)?

Trade Alert: The CEO & Executive Chairman Of China Regenerative Medicine International Limited (HKG:8158), Chuang Wang, Has Just Spent HK$55m Buying 428% More Shares

Dec 15
Trade Alert: The CEO & Executive Chairman Of China Regenerative Medicine International Limited (HKG:8158), Chuang Wang, Has Just Spent HK$55m Buying 428% More Shares

Don't Ignore The Fact That This Insider Just Sold Some Shares In China Regenerative Medicine International Limited (HKG:8158)

Nov 25
Don't Ignore The Fact That This Insider Just Sold Some Shares In China Regenerative Medicine International Limited (HKG:8158)

Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?

Nov 24
Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?

CEO Tazminat Analizi

Chuang Wang'un ücretlendirmesi China Regenerative Medicine International'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-HK$104m

Mar 31 2024n/an/a

-HK$101m

Dec 31 2023HK$1mHK$1m

-HK$108m

Sep 30 2023n/an/a

HK$677k

Jun 30 2023n/an/a

HK$15m

Mar 31 2023n/an/a

HK$5m

Dec 31 2022HK$1mn/a

HK$5m

Sep 30 2022n/an/a

HK$31m

Jun 30 2022n/an/a

HK$26m

Mar 31 2022n/an/a

HK$49m

Dec 31 2021HK$1mn/a

HK$52m

Sep 30 2021n/an/a

-HK$95m

Jun 30 2021n/an/a

-HK$82m

Mar 31 2021n/an/a

-HK$105m

Dec 31 2020HK$1mn/a

-HK$120m

Sep 30 2020n/an/a

-HK$201m

Jun 30 2020n/an/a

-HK$237m

Mar 31 2020n/an/a

-HK$239m

Dec 31 2019HK$245kHK$245k

-HK$264m

Tazminat ve Piyasa: Chuang 'ın toplam tazminatı ($USD 187.69K ) Hong Kong pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 233.11K ).

Tazminat ve Kazançlar: Chuang şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.


CEO

Chuang Wang (45 yo)

4.3yrs

Görev süresi

HK$1,461,000

Tazminat

Mr. Chuang Wang has been Executive Chairman at China Regenerative Medicine International Limited since October 18, 2019 and serves as its Chief Executive Officer since July 9, 2020 and also serves as its C...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Chuang Wang
CEO, Executive Chairman & Compliance Officer4.3yrsHK$1.46m24.28%
HK$ 23.3m
Po Tin Wong
CFO & Company Secretary2.2yrsVeri yokVeri yok
Jinnan Zhang
Chief Technology Officer6.2yrsVeri yokVeri yok

4.3yrs

Ortalama Görev Süresi

45yo

Ortalama Yaş

Deneyimli Yönetim: 8158 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.3 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Chuang Wang
CEO, Executive Chairman & Compliance Officer5.1yrsHK$1.46m24.28%
HK$ 23.3m
Man Fai Leung
Independent Non-Executive Director2.9yrsHK$120.00kVeri yok
Chunyu Huo
Independent Non-Executive Director4.8yrsHK$120.00kVeri yok
Ming Liu
Independent Non-Executive Director2.9yrsHK$120.00kVeri yok

3.9yrs

Ortalama Görev Süresi

58yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 8158 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.9 yıldır).